Aetna Inc. (NYSE:AET)‘s stock had its “neutral” rating reiterated by analysts at Cantor Fitzgerald in a report issued on Monday. They currently have a $175.00 price target on the stock. Cantor Fitzgerald’s price objective suggests a potential downside of 2.02% from the stock’s current price.

Several other equities research analysts have also issued reports on AET. Citigroup Inc. started coverage on shares of Aetna in a report on Wednesday, June 28th. They issued a “buy” rating and a $180.00 price target on the stock. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a report on Tuesday, July 4th. Credit Suisse Group reissued an “outperform” rating and issued a $165.00 price target (up previously from $160.00) on shares of Aetna in a report on Thursday, July 13th. Deutsche Bank AG boosted their price target on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a report on Thursday, July 13th. Finally, BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Nine research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Aetna currently has an average rating of “Buy” and an average price target of $162.36.

Aetna (NYSE:AET) traded down 0.32% on Monday, hitting $178.02. 3,478,646 shares of the stock were exchanged. The company’s 50 day moving average is $158.42 and its 200 day moving average is $150.77. Aetna has a 1-year low of $104.59 and a 1-year high of $180.57. The stock has a market cap of $59.12 billion, a PE ratio of 39.52 and a beta of 0.53.

Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.21 EPS. On average, equities research analysts expect that Aetna will post $9.48 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/23/aetna-inc-aet-given-buy-rating-at-cantor-fitzgerald.html.

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its position in Aetna by 3,374.9% during the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares during the period. Vanguard Group Inc. lifted its position in Aetna by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after purchasing an additional 838,578 shares during the period. Capital World Investors lifted its position in Aetna by 8.9% during the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. FMR LLC lifted its position in Aetna by 73.8% during the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after purchasing an additional 5,833,567 shares during the period. Finally, Janus Henderson Group PLC lifted its position in Aetna by 9,446.2% during the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares during the period. Institutional investors own 89.65% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.